Australia markets closed

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.60+0.11 (+2.00%)
At close: 04:00PM EDT
5.78 +0.18 (+3.21%)
Pre-market: 08:00AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
78,123
78,123
19,712
25,544
90,732
Operating expenses
Research development
177,651
177,651
174,958
142,507
157,996
Selling general and administrative
69,653
69,653
70,704
76,183
67,576
Total operating expenses
247,304
247,304
245,662
218,690
225,572
Operating income or loss
-169,181
-169,181
-225,950
-193,146
-134,840
Total other income/expenses net
-1,604
-1,604
1,293
37
16,259
Income before tax
-153,219
-153,219
-220,432
-192,502
-115,976
Income from continuing operations
-153,219
-153,219
-220,432
-192,502
-115,976
Net income
-153,219
-153,219
-220,432
-192,502
-115,976
Net income available to common shareholders
-153,219
-153,219
-220,432
-192,502
-115,976
Basic EPS
-2.69
-2.02
-3.21
-2.85
-1.98
Diluted EPS
-2.69
-2.02
-3.21
-2.85
-1.98
Basic average shares
72,721
75,966
68,665
67,619
58,609
Diluted average shares
72,721
75,966
68,665
67,619
58,609